Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.7824
$0.073410.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.33% | 11.80% | -44.60% | 6.38% | 26.18% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 262.57% | 201.74% | 52.78% | -7.47% | -17.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -38.05% | 26.42% | -38.92% | 4.61% | 25.24% |
|
|
|||||
| Total Current Assets | -38.05% | 26.42% | -38.92% | 4.61% | 25.24% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.59% | 41.64% | -32.00% | 4.61% | 25.24% |
|
|
|||||
| Total Accounts Payable | 63.24% | 66.29% | 77.22% | 99.98% | 9.34% |
| Total Accrued Expenses | -43.06% | 9.46% | 35.66% | 165.88% | 110.41% |
| Short-term Debt | -- | -62.70% | -6.74% | -50.26% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 24.99% | -- | -- | -- | 34.08% |
| Total Other Current Liabilities | 24.99% | -- | -- | -- | 34.08% |
| Total Current Liabilities | -14.98% | 34.53% | 51.43% | 120.91% | 72.41% |
|
|
|||||
| Total Current Liabilities | -14.98% | 34.53% | 51.43% | 120.91% | 72.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -62.70% | -6.74% | -50.26% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -88.97% | -91.08% | -85.17% | -36.99% | 42.17% |
| Total Liabilities | -18.30% | 26.64% | 37.90% | 108.56% | 70.78% |
|
|
|||||
| Common Stock & APIC | 17.86% | 31.95% | 28.41% | 35.62% | 35.35% |
| Retained Earnings | -22.27% | -30.91% | -35.78% | -45.02% | -41.29% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -85.79% | -17.17% | -472.66% | -123.26% | -31.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -85.79% | -17.17% | -472.66% | -123.26% | -31.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -85.79% | -17.17% | -472.66% | -123.26% | -31.87% |
|
|
|||||